Rare complication of COVID-19 presenting as isolated headache.

An 18-year-old man presented with persistent isolated headache 2 weeks after recovering from acute COVID-19 illness. Extensive cerebral venous sinus thrombosis (CVST) was detected on CT venogram despite him having no other thrombotic risk factors. CVST can complicate COVID-19. A high index of clinical suspicion is warranted as it can often have a subtle presentation with paucity of neurological symptoms.

Asif R ，O' Mahony MS 《-》

Extensive cerebral venous sinus thrombosis: a potential complication in a patient with COVID-19 disease.

A 63-year-old man was admitted with left-sided weakness and subsequent focal seizures following a recent diagnosis of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia in a nearby hospital. He developed status epilepticus and became comatose, requiring intensive care unit admission for invasive ventilation. Imaging done at admission confirmed extensive cerebral venous sinus thrombosis (CVST) with bilateral venous cortical infarcts and acute cortical haemorrhage. No known risk factor for CVST could be identified. He improved with anticoagulation and antiepileptic therapy. He was subsequently transferred to an inpatient rehabilitation facility. Although Coronavirus disease 19 (COVID-19) infection has been previously associated with thrombotic complications, these mostly relate to the pulmonary vasculature. We present this case as a potential association between CVST and COVID-19 infection.

Bolaji P ，Kukoyi B ，Ahmad N ，Wharton C ... -  《-》

A case report of extensive cerebral venous sinus thrombosis: a sequela of COVID-19?

Syed MO ，Sharmila A ，Sivalokanathan S 《-》

First case of Covid-19 presented with cerebral venous thrombosis: A rare and dreaded case.

Hemasian H ，Ansari B 《REVUE NEUROLOGIQUE》

COVID-19: A Potential Risk Factor for Acute Pulmonary Embolism.

A COVID-19-positive patient presented with pleuritic chest pain and cough and was found to have acute pulmonary embolisms (APEs). There has been an increase in observational reports of venous thromboembolic events in patients who are positive for COVID-19, especially in the setting of elevated inflammatory markers. The possibility of COVID-19 as an independent risk factor for APEs should be further explored in this novel pandemic.

Martin AI ，Rao G 《-》